AstraZeneca Annual Report and Form 20-F Information 2008

Notes to the Financial Statements (Group)

• 1 Operating profit
• 2 Finance income and expense
• 3 Taxation
• 4 Earnings per $0.25 Ordinary Share
• 5 Segment information

4 Earnings per $0.25 Ordinary Share

	2008	2007	2006
Profit for the financial year attributable to equity holders ($m)	6,101	5,595	6,043
Basic earnings per Ordinary Share	$4.20	$3.74	$3.86
Diluted earnings per Ordinary Share	$4.20	$3.73	$3.85
Weighted average number of Ordinary Shares in issue for basic earnings (millions)	1,453	1,495	1,564
Dilutive impact of share options outstanding (millions)	–	3	6
Diluted weighted average number of Ordinary Shares in issue (millions)	1,453	1,498	1,570

There are no options, warrants or rights outstanding in respect of unissued shares except for employee share option schemes. The number of options outstanding and the weighted average exercise price of these options is shown in Note 24. The earnings figures used in the calculations above are post-tax and are unchanged for diluted earnings per Ordinary Share.

Back to the top